Risk factors associated with linezolid-nonsusceptible enterococcal infections.

Authors :: McGregor JC
Hartung DM
Allen GP
Taplitz RA
Traver R
Tong T
Bearden DT
Source :: American journal of infection control [Am J Infect Control] 2012 Nov; Vol. 40 (9), pp. 886-7. Date of Electronic Publication: 2012 Feb 22.
Publication Year :: 2012
Abstract: Linezolid is one of few treatment options available for vancomycin-resistant enterococci. The present study investigated risk factors for linezolid-nonsusceptible enterococci using a case-control study of 15 cases and 60 control patients. Previous hospitalization, admission to a medical service, comorbidity, and linezolid and sulfonamide therapy were identified as risk factors.<br /> (Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.)